Parravano, Mariacristina
 Distribuzione geografica
Continente #
AS - Asia 2.964
NA - Nord America 2.515
SA - Sud America 973
EU - Europa 476
AF - Africa 150
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.086
Nazione #
US - Stati Uniti d'America 2.289
SG - Singapore 962
BR - Brasile 712
CN - Cina 573
BD - Bangladesh 467
HK - Hong Kong 314
IT - Italia 311
VN - Vietnam 170
MX - Messico 117
IN - India 100
AR - Argentina 91
CA - Canada 56
IQ - Iraq 46
ID - Indonesia 42
MA - Marocco 39
TR - Turchia 38
CO - Colombia 37
EC - Ecuador 36
PH - Filippine 33
PK - Pakistan 33
RU - Federazione Russa 31
SA - Arabia Saudita 31
ZA - Sudafrica 31
GB - Regno Unito 26
UZ - Uzbekistan 26
VE - Venezuela 26
MY - Malesia 25
TN - Tunisia 23
CL - Cile 20
FR - Francia 20
PY - Paraguay 20
DE - Germania 15
NL - Olanda 14
NP - Nepal 12
PE - Perù 12
UA - Ucraina 12
CR - Costa Rica 11
AE - Emirati Arabi Uniti 10
JM - Giamaica 10
JO - Giordania 10
EG - Egitto 9
UY - Uruguay 9
BO - Bolivia 8
ES - Italia 8
KZ - Kazakistan 8
ET - Etiopia 7
KE - Kenya 6
AZ - Azerbaigian 5
DZ - Algeria 5
GT - Guatemala 5
LB - Libano 5
PS - Palestinian Territory 5
QA - Qatar 5
TH - Thailandia 5
BY - Bielorussia 4
DO - Repubblica Dominicana 4
IL - Israele 4
OM - Oman 4
PA - Panama 4
PL - Polonia 4
TT - Trinidad e Tobago 4
BG - Bulgaria 3
BW - Botswana 3
CG - Congo 3
HN - Honduras 3
IE - Irlanda 3
JP - Giappone 3
KG - Kirghizistan 3
KH - Cambogia 3
KR - Corea 3
NI - Nicaragua 3
RO - Romania 3
RS - Serbia 3
AL - Albania 2
AO - Angola 2
AT - Austria 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
GE - Georgia 2
GR - Grecia 2
HT - Haiti 2
IR - Iran 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
MN - Mongolia 2
MR - Mauritania 2
MW - Malawi 2
MZ - Mozambico 2
NZ - Nuova Zelanda 2
RE - Reunion 2
SV - El Salvador 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
YE - Yemen 2
AD - Andorra 1
AM - Armenia 1
AU - Australia 1
BE - Belgio 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
Totale 7.053
Città #
San Jose 1.234
Singapore 512
Ashburn 377
Hong Kong 307
Beijing 272
Mexico City 90
Santa Clara 74
Ho Chi Minh City 57
Rome 56
São Paulo 49
New York 43
Hanoi 33
Milan 30
Buffalo 29
Los Angeles 27
Rio de Janeiro 21
Tashkent 21
Belo Horizonte 20
Guayaquil 16
Medellín 16
Baghdad 14
Dhaka 14
Curitiba 13
Dallas 12
Campinas 11
Da Nang 11
Porto Alegre 11
Quito 11
Salvador 11
Caracas 10
Jakarta 10
Johannesburg 10
Riyadh 10
Bologna 9
Brasília 9
Casablanca 9
Kuala Lumpur 9
Naples 9
Atlanta 8
Hải Dương 8
Jeddah 8
Kingston 8
Lahore 8
Lima 8
Montreal 8
San José 8
Toronto 8
Tunis 8
Amman 7
Caxias do Sul 7
Chandigarh 7
Chicago 7
Figino 7
Istanbul 7
New Delhi 7
Rabat 7
Seattle 7
Shanghai 7
Turin 7
Ankara 6
Asunción 6
Betim 6
Cali 6
Charlotte 6
Council Bluffs 6
Goiânia 6
Haiphong 6
Montevideo 6
Ninh Bình 6
Palermo 6
Philadelphia 6
Santiago 6
Addis Ababa 5
Alvorada 5
Amsterdam 5
Aryanah 5
Blumenau 5
Can Tho 5
Dammam 5
Delhi 5
Doha 5
Florence 5
João Pessoa 5
Karachi 5
Lucknow 5
Mumbai 5
Nairobi 5
Orem 5
Rosario 5
San Juan 5
Abu Dhabi 4
Albignasego 4
Anápolis 4
Araraquara 4
Baku 4
Baltimore 4
Bauru 4
Belém 4
Cape Town 4
Cleveland 4
Totale 3.842
Nome #
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials 87
Retinal micro-vascular and aortic macro-vascular changes in postmenopausal women with primary hyperparathyroidism 76
Retinal Sensitivity Loss Correlates with Deep Capillary Plexus Impairment in Diabetic Macular Ischemia 66
Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis 65
A quick, simple method for detecting circulating fluorescent advanced glycation end-products: Correlation with in vitro and in vivo non-enzymatic glycation 65
DRCR.net Trials for Diabetic Macular Edema 63
OCT-Angiography as a reliable prognostic tool in laser-treated proliferative diabetic retinopathy: The RENOCTA Study 63
Author Correction: Comparability of automated drusen volume measurements in age-related macular degeneration: a MACUSTAR study report (Scientific Reports, (2022), 12, 1, (21911), 10.1038/s41598-022-26223-w) 61
A gender-based analysis of retinal microvascular alterations in patients with diabetes mellitus using OCT angiography 59
Retinal Displacement after Idiopathic Macular Hole Surgery: Layer by Layer Analysis 56
Vision-related quality of life in patients treated for myopic choroidal neovascularization: A post hoc analysis of the OLIMPIC study 56
Author Correction: Microvascular impairment as a biomarker of diabetic retinopathy progression in the long-term follow up in type 1 diabetes (Scientific Reports, (2020), 10, 1, (18266), 10.1038/s41598-020-75416-8) 54
Intravitreal injection of bevacizumab: changes in intraocular pressure related to ocular axial length 54
Type 3 Macular Neovascularization in Age-related Macular Degeneration: Baseline Predictors of 3-Year Macular Atrophy Development 54
A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients 54
Morpho-Functional Macular Assessment in a Case of Facioscapulohumeral Muscular Dystrophy: Photoreceptor Degeneration as Possible Cause for Reduced Visual Acuity over Three Years of Follow-Up 53
Multimodal imaging characterization of peripheral drusen 51
Towards a better understanding of non-exudative choroidal and macular neovascularization 50
Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration treated with ranibizumab: 24-month results 49
Optical Coherence Tomography Angiography Findings in Active and Inactive Ocular Behçet Disease 48
Association between Visual Impairment and Depression in Patients Attending Eye Clinics: A Meta-analysis 47
Influence of Disc Size on Optic Nerve Head versus Retinal Nerve Fiber Layer Assessment for Diagnosing Glaucoma 46
Health Technology Assessment Report on Lucentis. 46
Use of the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) questionnaires for clinical decision-making and psychological referral in ophthalmic care: A multicentre observational study 45
OCTA characterisation of microvascular retinal alterations in patients with central serous chorioretinopathy 43
Aflibercept administration in neovascular age-related macular degeneration refractory to previous anti-vascular endothelial growth factor drugs: a critical review and new possible approaches to move forward 43
Survival and Health Care Burden of Children with Retinoblastoma in Europe 43
Quality of vision index: A new method to appraise visual function changes in age-related macular degeneration 42
Volume rendered 3D OCTA assessment of macular ischemia in patients with type 1 diabetes and without diabetic retinopathy 42
Ocular Biomarkers for Alzheimer Disease Dementia: An Umbrella Review of Systematic Reviews and Meta-analyses 41
Early and Late Morphological and Functional Changes After Verteporfin Photodynamic Therapy 41
A novel and atypical NF-KB pro-inflammatory program regulated by a CamKII-proteasome axis is involved in the early activation of Muller glia by high glucose 40
Morphofunctional evaluation in dome-shaped macula: A microperimetry and optical coherence tomography study 40
Curcumin Modulates the NMDA Receptor Subunit Composition Through a Mechanism Involving CaMKII and Ser/Thr Protein Phosphatases 40
Middle-Inner Macular Layers Dysfunction in a Case of Stellate Foveomacular Retinoschisis Detected by Abnormal Multifocal Photopic Negative Response Recordings 40
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2 40
Outer retina dysfunction and choriocapillaris impairment in type 1 diabetes 39
Imaging biomarkers of 1-year activity in type 1 macular neovascularization 39
Citicoline and Vitamin B12 Eye Drops in Type 1 Diabetes: Results of a 36-Month Pilot Study Evaluating Macular Electrophysiological Changes 38
A custom-made semiautomatic analysis of retinal nonperfusion areas after dexamethasone for diabetic macular edema 38
IL-8 and VEGFR-2 polymorphisms modulate long-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration 38
OCT retinal angiography features in patients with rheumatoid arthritis: A pilot study 38
A Novel Algorithm for the Evaluation of Corneal Nerve Beadings by in vivo Confocal Microscopy in Patients With Type 1 Diabetes Mellitus 38
Multimodal Study of PRPH2 Gene-Related Retinal Phenotypes 37
Whole Genome Sequencing Solves an Atypical Form of Bardet–Biedl Syndrome: Identification of Novel Pathogenic Variants of BBS9 36
Retreatment with Ozurdex for macular edema secondary to retinal vein occlusion 36
Investigation of Adaptive Optics Imaging Biomarkers for Detecting Pathological Changes of the Cone Mosaic in Patients with Type 1 Diabetes Mellitus 36
Anti-vascular endothelial growth factor for diabetic macular oedema 36
USING THREE-DIMENSIONAL OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY METRICS IMPROVES REPEATABILITY ON QUANTIFICATION OF ISCHEMIA IN EYES WITH DIABETIC MACULAR EDEMA 35
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials 35
Early and localized retinal dysfunction in patients with type 1 diabetes mellitus studied by multifocal electroretinogram 35
Progression Biomarkers of Microvascular and Photoreceptor Changes Upon Long-Term Evaluation in Type 1 Diabetes 34
Psychological profile and distinct salivary cortisol awake response (Car) in two different study populations with obstructive sleep apnea (osa) and central serous chorioretinopathy (csc) 34
Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials 34
Nascent Geographic Atrophy as a Predictor of Type 3 Macular Neovascularization Development 34
Faricimab versus the standard of care for neovascular age-related macular degeneration in Italy: an indirect treatment comparison 34
Long-term functional and morphologic retinal changes after ranibizumab and photodynamic therapy in myopic choroidal neovascularization 34
A Simple Spontaneous Vitreal Reflux Collecting Procedure During Intravitreal Injection: Set-Up and Validation Studies 33
The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design 33
Optical coherence tomography angiography in macular neovascularization: A comparison between different octa devices 33
Citicoline in ophthalmological neurodegenerative disease: A comprehensive review 33
Optical coherence tomography angiography characterization of evolving lesions in fellow eyes of exudative type 3 macular neovascularization patients 33
Anatomical and functional changes in neovascular AMD in remission: comparison of fibrocellular and fibrovascular phenotypes 33
Vitrectomy for idiopathic macular hole 32
ANALYSIS OF RETINAL CAPILLARIES IN PATIENTS WITH TYPE 1 DIABETES AND NONPROLIFERATIVE DIABETIC RETINOPATHY USING ADAPTIVE OPTICS IMAGING 32
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY ASSESSMENT OF THE DIABETIC MACULA: A Comparison Study Among Different Algorithms 32
Branch retinal artery occlusion caught in the act by an optical coherence tomography angiography image: case report 32
Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations 32
A COMMON FINDING IN FOVEAL-SPARING EXTENSIVE MACULAR ATROPHY WITH PSEUDODRUSEN IMPLICATES BASAL LAMINAR DEPOSITS 32
Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants 32
Effects of circadian rhythm disruption on retinal physiopathology: Considerations from a consensus of experts 32
Functional Correlates of Outer Retina Remodeling in Intermediate Age-Related Macular Degeneration Using Microperimetry 32
Development and Valuation of a Preference-Weighted Measure in Age-Related Macular Degeneration From the Vision Impairment in Low Luminance Questionnaire: A MACUSTAR Report 32
Interleukin-1 beta tear concentration in glaucomatous and ocular hypertensive patients treated with preservative-free nonselective beta-blockers 31
Multimodal imaging in diabetic retinopathy and macular edema: An update about biomarkers 31
Characteristics and Spatial Distribution of Structural Features in Age-Related Macular Degeneration: A MACUSTAR Study Report 31
Treatment of Diabetic Macular Edema with Multiple Dexamethasone Intravitreal Implants: Evidence from Real-Life Experience 31
Effectiveness of a Hydrophilic Curcumin-Based Formulation in Coadjuvating the Therapeutic Effect of Intravitreal Dexamethasone in Subjects With Diabetic Macular Edema 31
Intravitreal dexamethasone implant one month before versus concomitant with cataract surgery in patients with diabetic macular oedema: the dexcat study 31
Microperimetric retinal changes in myopic choroidal neovascularization treated with intravitreal ranibizumab 31
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials 31
Ischemic index changes in diabetic retinopathy after intravitreal dexamethasone implant using ultra-widefield fluorescein angiography: a pilot study 31
Citicoline and Vitamin B-12 Eye Drops in Type 1 Diabetes: Results of a 3-year Pilot Study Evaluating Morpho-Functional Retinal Changes 31
Cortisol awake response imbalance as an indicator of acute central serous chorioretinopathy: Relationship with choriocapillaris and choroidal features 31
Intravitreal Ranibizumab for Predominantly Hemorrhagic Choroidal Neovascularization in Age-Related Macular Degeneration 31
Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine 30
Utility values and electronic device use in low-vision people attending rehabilitation services: Data from a nation-wide registry in Italy 30
Advancements in Imaging and Therapeutic Options for Dry Age-Related Macular Degeneration and Geographic Atrophy 30
Intravitreal aflibercept for choroidal neovascularization due to age-related macular degeneration unresponsive to ranibizumab therapy 30
Neuroprotection by rat Muller glia against high glucose-induced neurodegeneration through a mechanism involving ERK1/2 activation 30
Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical Practice 30
Macular functional and morphological changes in intermediate age-related maculopathy 30
Exploring the biopsychosocial pathways shared by obstructive sleep apnea (Osa) and central serous chorioretinopathy (csc): A literature overview 29
Foveal Microstructure and Functional Parameters in Lamellar Macular Hole 29
Leveraging Optical Coherence Tomography and Angiography Artifacts to Identify Clinicopathological Correlates in Macular Disorders 29
Reticular pseudodrusen characterization by retromode imaging 29
ADAPTIVE OPTICS IMAGING OF PARAFOVEAL CONES IN TYPE 1 DIABETES 29
Photodynamic therapy with verteporfin for chronic central serous chorioretinopathy: A review of data and efficacy 29
Impact of intravitreal anti-VEGF therapy on intraretinal microvascular abnormalities in proliferative diabetic retinopathy 29
Functional and structural assessment of lamellar macular holes 29
Totale 3.953
Categoria #
all - tutte 31.513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.513


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.425 0 0 0 0 5 137 123 177 55 53 440 435
2025/20265.682 239 8 378 333 511 295 504 280 1.243 703 656 532
2026/2027219 219 0 0 0 0 0 0 0 0 0 0 0
Totale 7.326